PIAS1 is not suitable as a urothelial carcinoma biomarker protein and pharmacological target

• Holger Hans Hermann Erb ,

  Roles Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Supervision, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: holger.erb@uniklinikum-dresden.de

  Affiliations Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany, Department of Urology, Technische Universität Dresden, Dresden, Germany

  http://orcid.org/0000-0001-5209-7914

  ⨯
• Marlies Ebert,

  Roles Investigation, Methodology

  Affiliation Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany

  ⨯
• Ronja Kuhn,

  Roles Investigation, Methodology

  Affiliation Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany

  ⨯
• Lukas Donix,

  Roles Conceptualization, Methodology

  Affiliations Department of Urology, Technische Universität Dresden, Dresden, Germany, National Center for Tumor Diseases (NCT), Partner Site Dresden, Germany: German Cancer Research Center (DKFZ), Heidelberg, Germany; Faculty of Medicine and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany and Helmholtz Association/Helmholtz-Zentrum Dresden - Rossendorf (HZDR), Dresden, Germany

  ⨯
• Axel Haferkamp,

  Roles Supervision

  Affiliation Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany

  ⨯
• Robert Ian Seed,

  Roles Supervision, Visualization, Writing – review & editing

  Affiliation Department of Pathology, University of California, San Francisco, California, United States of America

  ⨯
• Eva Jüngel

  Roles Supervision

  Affiliation Department of Urology and Pediatric Urology, University Medical Center Mainz, Mainz, Germany

  ⨯